News of Note—Catalent upgrades Italy plant; Lonza adding ADC capacity

Microphone
(Pixabay)

> Catalent is investing $7.3 million at its Aprilia, Italy, facility to upgrade and expand its packaging and softgel encapsulation capabilities to 23 lines. Release

> CDMO Lonza says it will add two new manufacturing suites at its Visp, Switzerland, site to increase its capacity to manufacture antibody drug conjugate payloads. Release

> After investing €40 million to prepare for serialization to allow for the tracking of products, CDMO Recipharm says it has released its first serialized products to Europe from its facilities in Lisbon, Portugal, and Stockholm, Sweden. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.